Adequacy of access to investigative drugs for seriously ill patients View on Open Library

Adequacy of access to investigative drugs for seriously ill patients

by United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

No reviews yet
First published: 1997 1 language ISBN: 0160557593
Subjects
Clinical trials Drugs Testing Experimental Pharmacology Medical ethics Human experimentation in medicine Drug accessibility Drugs, testing

Reviews

Log in or sign up to write a review.

No reviews yet. Be the first!

More by United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

Clean Air Act amendments

Clean Air Act amendments

Medicare waste, fraud, and abuse, a regional perspective

Medicare waste, fraud, and abuse, a regi...

The Department of Energy's implementation of contract reform--problems with the fixed-price contract to clean up Pit 9

The Department of Energy's implementatio...

Department of Energy

Department of Energy

Privatization of the U.S. Enrichment Corporation and its impact on the domestic uranium industry

Privatization of the U.S. Enrichment Cor...

The federal-state relationship

The federal-state relationship

You Might Also Like

More in Clinical trials
Statistical Thinking for Non-Statisticians in Drug Regulation

Statistical Thinking for Non-Statisticia...

Richard Kay
Clinical trials

Clinical trials

Steven Piantadosi
Drugs

Drugs

Rick Ng
Practical guide to clinical data management

Practical guide to clinical data managem...

Susanne Prokscha
Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis

Hiroshi Mitsumoto
Multiple sclerosis therapeutics

Multiple sclerosis therapeutics

Richard A. Rudick